Clinical Trial Update: RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial comparing rivaroxaban to apixaban for heavy menstrual bleeding in people with venous thromboembolism has completed (PHASE 2/3), with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Indiana University | Conditions: Venous Thromboembolism, Menstruation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-05-10